Disease Areas

ALLEPRE: Long-term benefits of nurse-led secondary prevention programme for ACS

Presented By

Dr Giulia Magnani, University of Parma, Italy

Trial

ALLEPRE

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:39

Results for a deep learning ECG model relative to clinical assessment and current biomarkers

Presented By

Dr Antonius Büscher, University Hospital Münster, Germany

Conference

ACC 2025

Type

Peer-reviewed article

22 May 2025 14:00

ZODIAC: Can we improve lipid-lowering strategies in ACS?

Presented By

Prof. Ray Kausik, Imperial College London, UK

Conference

AHA 2024

Type

Peer-reviewed article

3 February 2025 15:00

IVUS-guided PCI beats angiography in patients with acute coronary syndrome

Presented By

Prof. Shao-Liang Chen, Nanjing Medical University, China

Trial

IVUS-ACS

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:40

ACS: Necessary DAPT after PCI may be shorter than currently advised

Presented By

Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

ULTIMATE-DAPT

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:29

Immediate or staged revascularisation in STEMI plus multivessel disease?

Presented By

Prof. Barbara Stähli, University of Zürich, Switzerland

Trial

MULTISTARS AMI

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:07

Lp(a) and cardiovascular events: which test is the best?

Presented By

Prof. Michael Szarek, University of Colorado, USA

Trial

Phase 3, ODYSSEY OUTCOMES

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:06

Guidelines for Acute Coronary Syndrome

Presented By

Prof. Borja Ibañez; Prof. Maria Rubini Gimene; Dr John Coughlan; Prof. Margret Leosdottir

Conference

ESC 2023

30 October 2023 16:04

Can aspirin be omitted after PCI in patients with high bleeding risk?

Presented By

Dr Masahiro Natsuaki, Saga University, Japan

Trial

Phase 4, STOPDAPT-3

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:03

DAPT or clopidogrel monotherapy after stenting in high-risk East-Asian patients?

Presented By

Prof. Yaling Han, General Hospital of Northern Theater Command, China

Trial

OPT-BIRISK

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

Immediate complete revascularisation non-inferior to staged complete revascularisation

Presented By

Dr Roberto Diletti, Erasmus MC, the Netherlands

Trial

BIOVASC

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 17:02

Half-dose tenecteplase safe and effective for STEMI without timely PCI

Trial

Phase 4, STREAM-2

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:15

Combination of filgrastim and dutogliptin appears safe in STEMI

Presented By

Prof. Markus Wallner , Medical University of Graz, Austria

Trial

Phase 2

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:44

ISAACC trial: CPAP controls blood pressure in ACS patients with severe OSA

Presented By

Dr Manuel Sánchez De La Torre, Lleida Biomedical Research Institute, Spain

Trial

ISAACC

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 11:34

COMPLETE revascularisation improves angina-related QoL

Presented By

Prof. Shamir Mehta, McMaster University, Canada

Trial

COMPLETE

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:24

Low-resource countries benefit from global STEMI initiative

Presented By

Prof. Cesar Herrera, Montefiore-Einstein Center for Heart and Vascular Care, USA

Trial

GHATI

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:44

Ticagrelor cessation: early CABG non-inferior to delayed surgery

Presented By

Dr Derek So, University of Ottowa Heart Institute, Canada

Trial

RAPID CABG

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:30

REVERSE-IT: Interim analysis shows promising effect of bentracimab on ticagrelor reversal

Presented By

Dr Deepak Bhatt, Brigham and Women’s Hospital, USA

Trial

Phase 3, REVERSE-IT

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:12

PIONEER III trial: Drug-eluting stents comparable

Presented By

Prof. Alexandra Lansky, Yale School of Medicine, USA

Trial

PIONEER III

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:30

2020 Non-ST-Segment Elevation Acute Coronary Syndromes Guidelines

Presented By

Prof. Jean-Phillippe Collet, Pitié-Salpêtrière Hospital, France

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:58

Trimetazidine after successful PCI not associated with fewer cardiac events

Presented By

Prof. Roberto Ferrari, University of Ferrara, Italy

Trial

ATPCI trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:30

Increased mortality with colchicine in patients with ACS

Presented By

Prof. Jamie Layland , Monash University, Australia

Trial

COPS trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:00

Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

Presented By

Prof. Y.S. Jang, Yonsei University, South Korea

Trial

TICO

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 15:29

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By

Prof. Renato D. Lopes, Duke University School of Medicine, USA

Trial

AUGUSTUS

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:59

Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

Presented By

Prof. J. Alexander, Duke University, USA

Trial

AUGUSTUS

Conference

ACC 2020

Type

Peer-reviewed article

8 September 2020 14:06

Drop aspirin after 3 months in non-STEMI ACS patients on dual antiplatelet therapy

Presented By

Prof. Usman Baber, Icahn School of Medicine at Mount Sinai, USA

Trial

TWILIGHT

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 20:58

Colchicine: no difference in peri-procedural cardiovascular events 30 days post-PCI

Presented By

Dr Binita Shah, NYU School of Medicine, USA

Trial

COLCHINE-PCI

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 17:04

Phase 3 BETonMACE trial did not meet its primary endpoint

Presented By

Prof. Kausik K. Ray, Imperial College London, United Kingdom

Trial

Phase 3, BETonMACE

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 15:47

Less bleeding and fewer hospitalisations with antithrombotic regimen with apixaban without aspirin

Trial

AUGUSTUS

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 13:19

Bempikibart shows its potential for hair regrowth in alopecia areata

Presented By

Dr Brett King, Yale Medicine, CT, USA

Trial

Phase 2, SIGNAL-AA

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 16:08

Ivarmacitinib stimulates hair regrowth in severe alopecia areata

Presented By

Prof. Jianzhong Zhang, Peking University People’s Hospital, China

Trial

Phase 3

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 15:51

Baricitinib regrows hair in adolescents with alopecia areata

Presented By

Prof. Thierry Passeron, Nice University Hospital, France

Trial

Phase 3, BRAVE-AA-PEDS

Conference

AAD 2025

Type

Peer-reviewed article

17 April 2025 15:41

Deuruxolitinib significantly improves hair satisfaction in AA

Presented By

Dr Paradi Mirmirani, Kaiser Permanente Vallejo Medical Center, USA

Trial

THRIVE-AA

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:56

Topical pan-JAK inhibitor mitigates inflammatory biomarkers in frontal fibrosing alopecia

Presented By

Prof. Maryanne Senna, Harvard Medical School, USA

Trial

Phase 2

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:51

What’s new in clinical dermatology?

Presented By

Dr Tamar Nijsten, Erasmus University Medical Centre, the Netherlands

Conference

DDD 2024

Type

Peer-reviewed article

31 May 2024 13:31

Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years

Presented By

Prof. Maryanne Senna, Harvard Medical School, USA

Trial

BRAVE-AA

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 16:43

Botanical drug solution leads to sustained hair regrowth in paediatric alopecia

Presented By

Prof. Bianca Piraccini, University of Bologna, Italy

Trial

RAAINBOW

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:14

SGLT2 inhibition: A possible mode-of-action for inflammatory skin diseases?

Presented By

Allison Holt, UMass Chan Medical School, USA

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 15:06

Ritlecitinib also effective in patients with total hair loss

Presented By

Dr Melissa Piliang, Cleveland Clinic, USA

Trial

Phase 3, ALLEGRO

Conference

AAD 2024

Type

Peer-reviewed article

22 April 2024 14:57

JAK3/TEC inhibition achieves clinically meaningful responses in AA

Presented By

Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany

Trial

Phase 3, ALLEGRO-LT

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:31

Alopecia areata: remarkable regrowth rates with deuruxolitinib

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Trial

Phase 3, THRIVE-AA

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:28

Botanical drug solution improves hair regrowth in children and adolescents with AA

Presented By

Prof. Ulrike Blume-Peytavi, Charité – Berlin University Medicine, Germany

Trial

RAAINBOW

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 10:23

Patients with AA report high long-term regrowth rates with baricitinib

Presented By

Dr Maryanne Senna, Harvard Medical School, MA, USA

Trial

BRAVE-AA1 and BRAVE-AA2

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:22

Can ritlecitinib deliver long-term efficacy in alopecia areata?

Presented By

Prof. Melissa Piliang, Cleveland Clinic, OH, USA

Trial

Phase 3, ALLEGRO

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:18

TikTok videos on hair disorders lack reliability

Presented By

Dr Betty Nguyen, University of Miami, FL, USA

Conference

WCD 2023

Type

Peer-reviewed article

31 August 2023 15:14

JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata

Presented By

Dr Maryanne Senna, Lahey Hospital and Medical Center, MA, USA

Trial

Phase 3, THRIVE-AA1

Conference

AAD 2023

Type

Peer-reviewed article

15 May 2023 12:41

The rise of JAK inhibitors for alopecia areata

Presented By

Dr Brett King, Yale University, CT, USA

Conference

DDD 2023

Type

Peer-reviewed article

10 May 2023 13:47

Long-term improvement in alopecia areata with ritlecitinib therapy

Presented By

Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany

Trial

Phase 3, ALLEGRO-LT

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:30

Topical gel plus finasteride beneficial for patients with androgenetic alopecia

Presented By

Dr Michela Starace, University of Bologna, Italy

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:20

Deuruxolitinib achieves hair regrowth, even in patients with severe alopecia areata

Presented By

Prof. Brett King, Yale University School of Medicine, CT, USA

Trial

Phase 3, THRIVE-AA1

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 09:18

EADV 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EADV 2022

27 September 2022 11:49

No adverse pregnancy outcomes in patients exposed to baricitinib

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:47

Alopecia areata: light at the end of the tunnel

Presented By

Prof. Maryanne Senna , Harvard Medical School, MA, USA

Trial

Phase 3, BRAVE-AA1, BRAVE-AA2

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:01

Alopecia areata pathogenesis: known genetic background, unknown environmental triggers

Presented By

Prof. Rodney Sinclair , University of Melbourne, Australia

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 09:56

Alopecia areata: 1-year baricitinib treatment increases success

Presented By

Prof. Brett King, Yale School of Medicine, USA

Trial

Phase 3, BRAVE-AA1; BRAVE-AA2

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 10:35

JAK1/2: A promising novel treatment target in alopecia areata

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Trial

Phase 3, BRAVE-AA1; BRAVE-AA2

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:12

Alopecia areata: encouraging response rates with JAK3/TEC inhibition

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Trial

ALLEGRO

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:11

Allergies: an underrated factor in alopecia pathogenesis

Presented By

Prof. Natasha Mesinkovska, UC Irvine School of Medicine, CA, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:45

Botulinum toxin A: a contradictory role in hair loss

Presented By

Prof. Natasha Mesinkovska, UC Irvine School of Medicine, CA, USA

Conference

aad vmx 2021

Type

Peer-reviewed article

7 June 2021 13:21

Platelet-rich plasma in androgenetic alopecia – hype or hope?

Presented By

Prof. Ronda S. Farah, University of Minnesota, MN, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:00

JAK inhibitors in AA: re-establishing the immune privilege of hair follicles

Presented By

Prof. Taisuke Ito, Hamamatsu University School of Medicine, Japan

Conference

EADV 2020

Type

Peer-reviewed article

17 December 2020 14:27

Spironolactone safe for androgenetic alopecia in cancer survivors

Presented By

Dr Chapman Wei, George Washington University, USA

Conference

AAD 2020

Type

Peer-reviewed article

19 August 2020 07:33

Novel JAK1/2 inhibitor shows remarkable efficacy in alopecia areata

Presented By

Dr James Cassella

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 18:54

Novel treatment options in alopecia areata and vitiligo

Presented By

Prof. Brett King, Yale University School of Medicine, USA

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 18:20

JAK1/2 inhibitor effective in alopecia areata

Presented By

James Cassella, Concert Pharmaceuticals, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 21:21

JAK inhibitors: a pathogenesis-directed therapy for alopecia areata

Presented By

Prof. Brittany Craiglow, Yale University School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 19:10

Hair Loss: No Reason for Therapeutic Nihilism

Presented By

Dr Glynis Ablon, Dr Melissa Piliang, Prof. Antonella Tosti, Dr Jeff Donovan

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:16

A glimpse into the future

Presented By

Prof. Wilma Bergfeld, Cleveland Clinic, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 18:08

New agents and combination therapy

Presented By

Prof. Wilma Bergfeld, Cleveland Clinic, USA

Conference

AAD 2018

Type

Peer-reviewed article

20 December 2018 17:11

Lecanemab in AD: not a paradigm shift, but a small step forward

Presented By

Dr Matilde Bruno, University of Rome Tor Vergata, Italy

Conference

EAN 2025

Type

News article

25 June 2025 10:49

Dementia doubles mortality risk 1 year after hip fracture

Presented By

Prof. Dorota Religa, Karolinska Institutet, Sweden

Conference

EAN 2025

Type

News article

25 June 2025 10:48

AF and dementia: largest Mediterranean cohort reveals age-dependent association

Presented By

Dr Julian Rodríguez-García, Bellvitge University Hospital, Barcelona, Spain

Conference

EHRA 2025

Type

News article

6 May 2025 11:34

Vagal nerve stimulation for the reduction of cognitive impairment in Alzheimer’s disease

Presented By

Dr Adam Broncel, Neuromedical, Poland

Conference

EAN 2024

Type

News article

25 July 2024 11:07

Under investigation: Opioid use and the risk for dementia

Presented By

Dr Nelsan Pourhadi, Copenhagen University Hospital Rigshospitalet, Denmark

Conference

EAN 2024

Type

News article

25 July 2024 10:45

Intensive BP intervention reduces risk of dementia 

Presented By

Dr Jiang He, Tulane University, USA

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 14:01

Nightmares during childhood linked to cognitive decline later in life

Presented By

Dr Abidemi Otaiku, University of Birmingham, UK

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 11:55

Towards cell biology of Alzheimer’s disease

Presented By

Prof. Thomas C. Südhof, Stanford Medicine, CA, USA

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 10:35

Contribution of genomics and genetics to personalised medicine

Presented By

Prof. Nicholas Wood, University College London, UK

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 09:56

How big data can boost care for neurodegenerative disorders

Presented By

Prof. Gunhild Waldemar, University of Copenhagen, Denmark

Conference

EAN 2023

Type

Peer-reviewed article

7 September 2023 09:46

Alzheimer’s disease and dementia: the road towards proactive and preventive care

Expert

Dr John Showalter, Linus Health, Boston, MA, USA

21 August 2023 14:51

Lecanemab may slow decline of cognition and function in Alzheimer’s Disease

Presented By

Prof. Christopher van Dyck, Yale School of Medicine, CT, USA

Trial

Phase 3, CLARITY AD

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 19:44

Donanemab shows rapid and deep plaque clearance in early Alzheimer’s Disease

Presented By

Prof. Stephen Salloway, Warren Alpert Medical School of Brown University, RI, USA

Trial

Phase 3, TRAILBLAZER-ALZ 4

Conference

AAN 2023

Type

Peer-reviewed article

26 June 2023 19:38

Key correlates of incident dementia identified in the MESA study

Presented By

Dr Mohammad Ostovaneh, Johns Hopkins Hospital, MD, USA

Trial

MESA

Conference

ACC 2023

Type

Peer-reviewed article

7 June 2023 09:03

Looking Forward to 2023: Anticipated Medical Innovations

25 January 2023 02:35

Diabetes not related to abnormal biomarkers of Alzheimer’s disease

Presented By

Veerle van Gils, Maastricht University, the Netherlands

Conference

ECNP 2022

Type

Peer-reviewed article

28 November 2022 10:53

Large impact of COVID-19 on dementia diagnosis and care

Presented By

Prof. Bengt Winblad, Karolinska Institutet, Sweden

Conference

EAN 2022

Type

Peer-reviewed article

22 August 2022 16:49

Risk factors for dementia in RA patients discovered

Presented By

Prof. Elena Myasoedova , Mayo Clinic, MN, USA

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 15:02

EAN 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

EAN 2022

14 July 2022 09:07

Roche’s study flop marks yet another Alzheimer’s setback

16 June 2022 15:27

Biologic treatment decreases dementia risk in senior IBD patients

Presented By

Dr Ahmed Eltelbany, Cleveland Clinic, OH, USA

Conference

DDW 2022

Type

News article

14 June 2022 22:12

Aortic stiffness a modifiable risk factor for dementia?

Journal

JAMA Neurology

7 June 2022 16:15

Cardiorespiratory fitness protects against dementia

Presented By

Dr Edward Zamrini, Washington DC VA Medical Center, DC, USA

Conference

AAN 2022

Type

Peer-reviewed article

2 June 2022 12:12

Safety and effects of bosutinib in Lewy body dementia

Presented By

Dr Fernando Pagán, Georgetown University Hospital, DC, USA

Conference

AAN 2022

Type

Peer-reviewed article

2 June 2022 12:06

Biogen pulls application for Alzheimer’s drug in Europe

22 April 2022 19:23

AAN 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AAN 2022

19 April 2022 22:42

Late-onset alcohol abuse may signal dementia

Journal

Journal of Alzheimer's Disease

18 April 2022 23:27

Stroke treatment effective for individuals with disability or dementia: AHA/ASA

Journal

Stroke

8 April 2022 22:10

Eisai seeking accelerated FDA review of Alzheimer’s drug after U.S. coverage decision

8 April 2022 21:29

Study links drowsiness in Alzheimer’s to wake-promoting brain regions

Journal

JAMA Neurology

7 April 2022 15:24

Computational model of Alzheimer’s links symptoms, brain anatomy, mental processing

Journal

Nature Communications

5 April 2022 22:40

Atrial myopathy may contribute to dementia risk

Journal

JAMA

22 March 2022 17:28

Biogen publishes Alzheimer’s drug data in lesser-known journal

Journal

Journal of Prevention of Alzheimer's Disease

18 March 2022 17:38

Tau buildup in brain tied to psychosis, more rapid decline in Alzheimer’s disease

Journal

Translational Psychiatry

11 March 2022 23:11

Poor score on a simple memory test tracks with Alzheimer’s biomarkers

Journal

Neurology

1 March 2022 18:50

Certain antihypertensive meds might help prevent cognitive decline

Journal

JAMA Network Open

11 February 2022 15:59

Alzheimer’s-like changes seen in COVID-19 patients’ brains

Journal

Alzheimer's & Dementia; bioRxiv; Preprints with The Lancet

4 February 2022 23:44

Reduced risk of Alzheimer’s disease in CHIP carriers

Presented By

Dr Hind Bouzid, Stanford University, CA, USA

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 10:49

Drugs that boost neurotrophic support might be helpful in early dementia

Journal

JAMA Neurology

31 January 2022 23:08

Dementia risk increased after ischemic stroke

Journal

JAMA Neurology

28 January 2022 16:15

After initial dip, dementia risk rises with diabetes duration

Journal

Age and Ageing

12 January 2022 16:04

After initial dip, dementia risk rises with diabetes duration

Journal

Age and Ageing

12 January 2022 16:04

Post-traumatic amnesia, chronic vascular lesions risk factors for Alzheimer’s after TBI

Journal

Alzheimer Disease & Associated Disorders

6 January 2022 20:41

Senescent cells with neurofibrillary tangles identified as potential Alzheimer’s treatment target

Journal

Nature Aging

23 December 2021 01:32

Cataract extraction linked to lower dementia risk

Journal

JAMA Internal Medicine

15 December 2021 22:13

Online self-test detects mild cognitive impairment shift to dementia sooner than MMSE

Journal

Alzheimer's Research and Therapy

13 December 2021 22:18

Sildenafil use tied to reduced risk of Alzheimer’s

Journal

Nature Aging

10 December 2021 22:01

Researchers find ‘promising’ blood biomarkers for cognitive decline in dementia

Journal

JAMA Neurology

3 December 2021 18:27

Impaired blood-brain barrier may underlie Parkinson’s disease progression

Journal

Neurology Genetics

26 November 2021 21:59

Amyloid-related imaging abnormalities seen in about 40% of aducanumab users in clinical trials

Journal

JAMA Neurology

25 November 2021 16:28

Biogen’s Alzheimer’s drug gets negative European panel vote

17 November 2021 15:23

Premenopausal oophorectomy tied to increased risk of cognitive impairment

Journal

JAMA Network Open

16 November 2021 22:46

Biogen says Aduhelm lowers levels of second protein associated with Alzheimer’s

12 November 2021 15:27

MEF2 expression linked to cognitive resilience in Alzheimer’s disease

Journal

Science Translational Medicine

9 November 2021 21:32

Tau replication in local brain regions, not spread between regions, drives Alzheimer’s pathology

Journal

Science Advances

3 November 2021 22:05

Brain white matter connectivity disrupted in symptomless, early-onset Alzheimer’s

Journal

Radiology

22 October 2021 23:51

Blood GFAP a sensitive biomarker for early Alzheimer’s disease

Journal

JAMA Neurology

18 October 2021 22:39

Tau accumulation in brain likely best biomarker of short-term cognitive decline in Alzheimer’s

Journal

Molecular Psychiatry

13 October 2021 22:54

Diuretic shows promise for dementia prevention and treatment

Journal

Nature Aging

12 October 2021 17:14

Menopausal hormone therapy not linked to dementia risk

Journal

The BMJ

7 October 2021 23:04

Methylphenidate safe, effective for apathy in Alzheimer disease

Journal

JAMA Neurology

5 October 2021 23:34

Study confirms link between dementia risk and eye disorders

Journal

British Journal of Ophthalmology

5 October 2021 17:19

Not all amyloid-beta assays and methods perform equally well

Journal

JAMA Neurology

24 September 2021 16:51

Sleep duration associated with amyloid burden and cognitive decline

Journal

JAMA Neurology

22 September 2021 22:56

Major surgery raises plasma biomarkers of brain injury, dementia risk

Journal

JAMA Neurology

22 September 2021 16:32

Study questions screening for subclinical thyroid dysfunction to prevent cognitive decline

Journal

JAMA Internal Medicine

8 September 2021 23:30

Number of people with dementia set to jump 40% to 78 mln by 2030 -WHO

2 September 2021 15:24

Severe outcomes of COVID-19 in patients with dementia

Presented By

Dr Agathe Vrillon, Hôpital Lariboisière Fernand-Widal, France

Conference

EAN 2021

Type

Peer-reviewed article

18 August 2021 10:27

Promising diagnostic accuracy of plasma GFAP

Presented By

Dr Tandis Parvizi, Medical University of Vienna, Austria

Conference

EAN 2021

Type

Peer-reviewed article

18 August 2021 10:10

Sex modulates effect of cognitive reserve on subjective cognitive decline

Presented By

Dr Giulia Giacomucci, University of Florence, Italy

Conference

EAN 2021

Type

Peer-reviewed article

18 August 2021 10:05

Hypersensitivity to uncertainty in subjective cognitive decline

Presented By

Dr Bahaaeddin Attaallah, University of Oxford, United Kingdom

Conference

EAN 2021

Type

Peer-reviewed article

18 August 2021 10:00

Global young-onset dementia prevalence 119 per 100,000

Journal

JAMA Neurology

19 July 2021 23:20

APOE-e4 allele tied to Alzheimer’s clinical and biomarker changes in Down syndrome

Journal

JAMA Neurology

14 July 2021 23:20

Calculator validated for home-based dementia risk screening

Journal

Journal of Epidemiology and Community Health

8 July 2021 22:37

Statins not tied to incident dementia or cognitive decline in older adults

Journal

Journal of the American College of Cardiology

29 June 2021 23:51

Motor change patterns may suggest preclinical Alzheimer’s disease

Journal

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

29 June 2021 23:33

Biogen working to speed up confirmatory study for approved Alzheimer’s drug

24 June 2021 16:20

Lilly to seek accelerated FDA approval for Alzheimer’s drug this year

24 June 2021 16:18

FDA documents show struggle over approval of new Alzheimer’s drug from Biogen

22 June 2021 23:41

Rival treatments may help justify FDA gamble with Biogen Alzheimer’s drug

18 June 2021 16:43

Obstructive sleep apnoea associated with lower cognition

Presented By

Dr David Colelli, University of Toronto, Canada

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:49

NfL is a better marker for neurodegeneration than T-tau

Presented By

Mr Jordan Marks, Mayo Clinic, MN, USA

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:49

Monoclonal antibody rapidly reduces brain amyloid

Presented By

Dr Chad Swanson, Neurology Business Group, Eisai Inc., NJ, USA

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:44

Breast cancer treatment decreases risk of dementia

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:43

Pimavanserin does not worsen motor function in patients with neurodegenerative disease

Trial

HARMONY, 019, 046, 032

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:42

Lipophilic statins may raise risk of conversion from MCI to dementia

Conference

Society of Nuclear Medicine and Molecular Imaging 2021 annual meeting

15 June 2021 15:40

Cholesterol catabolism, bile acid synthesis tied to dementia risk in men

Journal

PLoS Medicine

11 June 2021 23:20

ANALYSIS-U.S. FDA faces mounting criticism over Alzheimer’s drug approval

11 June 2021 15:32

Gene signature for plaque-eating microglia identified

Journal

Nature Communications

2 June 2021 22:54

Biological definition of Alzheimer’s disease not suitable for clinical diagnosis

Journal

The Lancet Neurology

21 May 2021 20:46

Memory decline in older adults similar with CABG and PCI

Journal

JAMA

18 May 2021 23:08

Video exam may be effective alternative to in-person cognitive assessments

Journal

Journal of the American Geriatrics Society

14 May 2021 23:22

Novel compound reverses Alzheimer’s disease in mice

Journal

Cell

7 May 2021 22:13

New PET tracer detects early hallmark of Alzheimer’s disease

Journal

Molecular Psychiatry

6 May 2021 22:03

Dense-core amyloid plaques may be protective, not destructive, in Alzheimer’s disease

Journal

Nature Immunology

3 May 2021 22:40

Whole-genome sequencing reveals rare variants tied to Alzheimer’s disease

Journal

Alzheimer's and Dementia

15 April 2021 23:21

More evidence that gum disease may play a role in Alzheimer’s disease

Journal

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

14 April 2021 18:26

Adults with recent dementia diagnosis at increased risk for suicide

Journal

JAMA Psychiatry

5 April 2021 22:03

Retinal changes may signal pre-clinical Alzheimer’s disease neuropathology

Journal

JAMA Ophthalmology

2 April 2021 17:11

Sargramostim shows promise in Alzheimer’s disease

Journal

Alzheimer's and Dementia: Translational Research and Clinical Interventions

30 March 2021 23:53

Retinal damage may signal risk for stroke and dementia

Conference

American Stroke Association International Stroke Conference 2021

25 March 2021 16:01

Little consensus on referral to specialist palliative care for dementia patients

Journal

Journal of the American Geriatrics Society

19 March 2021 20:56

Link between cardiovascular-risk management and dementia protection remains elusive

Journal

JAMA Neurology

10 March 2021 15:43

Reverse BP dipping tied to dementia, Alzheimer’s disease in older men

Journal

Hypertension

19 February 2021 23:37

Hyperglycemia tied to cognitive decline, vascular dementia

Journal

Diabetes, Obesity, and Metabolism

19 February 2021 19:21

Visual reads of PET scans can help predict near-term clinical progression of dementia

Journal

JAMA Neurology

18 February 2021 18:07

Benign prostatic hyperplasia tied to Alzheimer’s disease risk

Journal

EClinicalMedicine

16 February 2021 23:06

Tau species in spinal fluid may track with brain tau, indicate stage of dementia

Journal

Brain

21 December 2020 16:14

High risk of vascular dementia in patients with T2D

Presented By

Dr Carlos Celis-Morales, University of Glasgow, Scotland

Conference

EASD 2020

Type

News article

14 December 2020 12:36

Study supports link between endosomal-traffic defect and Alzheimer’s

Journal

Science Translational Medicine

4 December 2020 19:52

Neuroinflammation common in familial frontotemporal dementia

Journal

Journal of Neurology, Neurosurgery and Psychiatry

26 November 2020 20:00

Retinal imaging may predict Alzheimer’s in those at genetic risk

Journal

JAMA Ophthalmology

20 November 2020 17:11

Plasma P-tau217 emerging as biomarker of early AD

Journal

JAMA Neurology

11 November 2020 18:18

Predicting MCI and dementia by assessing worrying about memory

Presented By

Prof. Frank Jessen, University Hospital of Cologne, Germany

Trial

Cohort study, AgeCoDe

Conference

ECNP 2020

Type

Peer-reviewed article

2 November 2020 16:49

Genomics of vascular dementia and stroke

Presented By

Prof. Elisabeth Tournier-Lasserve, Saint Louis Hospital, France

Conference

ECNP 2020

Type

Peer-reviewed article

2 November 2020 16:45

The PRISM project: focusing on biological parameters across neuropsychiatric disorders

Presented By

Dr Hugh Marston, Eli Lilly and Company Ltd, Germany

Conference

ECNP 2020

Type

Peer-reviewed article

2 November 2020 15:56

APOE-region variants linked to Alzheimer’s disease risk

Journal

JAMA Network Open

30 October 2020 22:18

Unique Alzheimer’s disease risk loci found in African Americans

Journal

JAMA Neurology

23 October 2020 20:20

Novel neuroimaging data have implications for recruitment for Alzheimer’s clinical trials

Journal

JAMA Neurology

21 October 2020 16:48

Telemedicine could help rural patients with dementia

Journal

Maturitas

16 October 2020 22:11

Sleep EEG-based brain-age index correlates with dementia

Journal

JAMA Network Open

8 October 2020 18:23

French ‘Alzheimer’s village’: where nursing home meets the outside world

1 October 2020 16:11

Non-Alzheimer’s disease pathophysiology in the elderly

Expert

Prof. Philip Scheltens, Amsterdam UMC, the Netherlands

Conference

EAN 2020

Type

Peer-reviewed article

8 September 2020 10:58

Novel genetic association with resistance to ERC tau deposition

Expert

Vijay K Ramanan, Mayo Clinic–Rochester, Minnesota, USA

Conference

EAN 2020

Type

Peer-reviewed article

8 September 2020 10:55

News on AD biomarkers

Conference

EAN 2020

Type

Peer-reviewed article

8 September 2020 10:50

Diastolic dysfunction novel risk factor for cognitive impairment

Expert

Dr A. Parker, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, USA

Conference

EAN 2020

Type

Peer-reviewed article

8 September 2020 10:08

A necessary shift of focus to the earlier stages of Alzheimer’s

Presented By

Prof. Bart de Strooper, Katholieke Universiteit Leuven, Belgium

Conference

EAN 2019

Type

Peer-reviewed article

27 August 2019 23:51

Biomarkers and how to use them

Conference

EAN 2019

Type

Peer-reviewed article

27 August 2019 22:54

Antipsychotics increase mortality regardless of comorbidity

Presented By

Dr Ane Nørgaard, Rigshospitalet, Denmark

Conference

EAN 2019

Type

Peer-reviewed article

27 August 2019 21:55

PDD and DLB represent two different disorders

Conference

EAN 2019

Type

Peer-reviewed article

27 August 2019 14:57

Amyloid PET in cognitively impaired patients

Presented By

Prof. Gil Rabinovici, University of California San Francisco, USA

Trial

IDEAS

Conference

AAN 2019

Type

Peer-reviewed article

30 July 2019 23:14

Tight blood pressure control lowers risk of mild cognitive impairment

Presented By

Dr Jeff Williamson, Wake Forest Baptist Medical Center, Winston-Salem, USA

Trial

SPRINT MIND

Conference

AAN 2019

Type

Peer-reviewed article

30 July 2019 22:16

Two experimental antibodies reduce amyloid levels

Trial

Phase 3, PRIME, ENGAGE, EMERGE

Conference

AAN 2019

Type

Peer-reviewed article

30 July 2019 21:20

How to implement brain-healthy behaviour in clinical practice

Conference

AAN 2019

Type

Peer-reviewed article

30 July 2019 09:21

ICI therapy does not increase mortality risk in patients with pre-existing autoimmune disease

Presented By

Dr Greg Challener, Massachusetts General Hospital, MA, USA

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:09

Registry participation can enhance quality of rheumatology care

Presented By

Dr Gabriela Schmajuk, University of California, San Francisco, CA, USA

Conference

ACR 2024

Type

Peer-reviewed article

13 January 2025 11:07

Dual IL-17A/F blocker significantly reduces spinal radiographic progression in radiographic axSpA

Presented By

Prof. Xenofon Baraliakos, Ruhr-University Bochum, Germany

Trial

Phase 3, BE MOBILE 2

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:38

AxSpA: Higher comorbidity burden worsens radiographic progression

Presented By

Dr Sizheng Steven Zhao, University of Manchester, UK

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:32

Low IL-18: a hidden culprit of long COVID in patients with autoimmune disease

Presented By

Dr Jeffrey Sparks, Brigham and Women's Hospital, MA, USA

Trial

RheumCARD

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:29

AxSpA: Adalimumab biosimilar equally effective as IL-17 inhibitor in hindering radiographic progression

Presented By

Prof. Xenofon Baraliakos, Rheumazentrum Ruhrgebiet, Germany

Trial

Phase 3, SURPASS

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 06:22

Ankylosing spondylitis: Combining biologics with NSAID does not imply reduced radiographic progression

Presented By

Dr Fabian Proft, Charité University Hospital, Germany

Trial

Phase 4, CONSUL

Conference

ACR 2022

Type

News article

1 December 2022 14:08

Alarmingly low activity in patients with non-inflammatory and inflammatory rheumatic disease

Presented By

Prof. Luca Quartuccio, University of Udine, Italy

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 19:31

How to treat enthesitis in 2022

Presented By

Prof. Dennis McGonagle, University of Leeds, United Kingdom

Trial

Phase 3, SEAM-PsA, EXCEED, SPIRIT-H2H

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:42

Treat-to-target dose reduction effective in spondyloarthritis

Presented By

Dr Celia Michielsens , Sint Maartenskliniek, the Netherlands

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:21

A novel oral treatment possibility for non-radiographic axSpA on the horizon

Presented By

Prof. Filip van den Bosch , Ghent University, Belgium

Trial

Phase 3, SELECT-AXIS 2

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:17

EULAR 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

EULAR 2022

22 June 2022 23:51

SELECT-AXIS: 64-week results of upadacitinib in active ankylosing spondylitis

Presented By

Dr Atul Deodhar, Oregon Health & Science University, OR, USA

Trial

SELECT-AXIS 1

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:25

JAK inhibition as a treatment option for ankylosing spondylitis

Presented By

Prof. Atul Deodhar, Oregon Health & Science University, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 11:02

Signs of benefit for T2T in axial spondyloarthritis

Trial

Cohort study, TICOSPA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:53

Artificial intelligence can help in the diagnosis of axSPA

Presented By

Prof. Denis Poddubnyy, Charité Universitätsmedizin Berlin, Germany

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:53

Reduced maintenance dose of certolizumab pegol can be used in axSpA

Presented By

Prof. Robert Landewé, University of Amsterdam, the Netherlands

Trial

C-OPTIMISE

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:30

Worse response axSpA patients to second TNFi versus first TNFi

Presented By

Dr Santiago Rodrigues-Manica, Hospital Egas Moniz, Portugal

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:27

AxSpA real-life remission rates higher on biologics

Presented By

Dr Charlotte Baert, Saint Luc University Hospital, Belgium

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:24

Certolizumab pegol reduces acute anterior uveitis in axial spondyloarthritis

Presented By

Prof. Irene van der Horst-Bruinsma, Amsterdam University Medical Center, the Netherlands

Trial

C-VIEW

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:19

TNF-α inhibitors improve bone mineral density in AS patients

Presented By

Mark Siderius, University Medical Center Groningen; Medical Center Leeuwarden, the Netherlands

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:13

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By

Dr Evelyne Vinet, McGill University, Montreal, Canada

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:12

JAK1 inhibition shows remarkable efficacy in AS

Presented By

Prof. Désirée van der Heijde, Leiden University Medical Center, the Netherlands

Trial

Phase 3, SELECT-AXIS 1

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 20:57

CARDAS study shows increased prevalence of cardiac valvular disorders in AS patients

Presented By

Mr Milad Baniaamam, Amsterdam University Medical Center, the Netherlands

Trial

CARDAS

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:04

Treat-to-target approach emerging in axial spondyloarthritis

Presented By

Dr Pedro Machado, University College London Hospitals, United Kingdom

Trial

TICOPA, TICORA, TICOSPA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 23:10

NSAIDs consumption is linked to patient-assessed disease activity and decreases with use of TNF inhibitors

Presented By

Dr Olafur Palsson, University Hospital Reykjavik, Iceland

Trial

ICEBIO database

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:11

IBD risk of treatment with IL-17 antagonists

Presented By

Dr Wolfgang Eigner, Medical University of Vienna, Austria

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 14:37

Clinical effect of vedolizumab on articular manifestations spondyloarthritis associated with IBD

Presented By

Dr. Paccou, Amiens University Medical Center, France

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 23:43

Osteoporosis and vertebral fractures associated with disease activity/radiographic damage in axial spondyloarthritis

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 23:38

Synergistic effect NSAIDs plus TNFi in slowing radiographic progression in ankylosing spondylitis patients

Presented By

Dr Gensler, University of California San Francisco Medical Center, USA

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 22:48

Switching to biosimilar bDMARDs is safe and efficacious

Presented By

Prof. Kvien, University of Oslo and Diakonhjemmet Hospital, Norway

Trial

Phase 4, NOR-SWITCH

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 22:46

Low bone mineral density is common in axial spondyloarthritis; more awareness required

Trial

Cohort study, axSpA

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 20:52

Anxiety and depression: Lifestyle influential in MACE prevention

Presented By

Dr Shady Abohashem, Massachusetts General Hospital, USA

Trial

Mass General Brigham Biobank

Conference

ACC 204

Type

Peer-reviewed article

16 May 2024 13:57

Worse self-management in patients with inflammatory arthritis in the presence of comorbid anxiety or depression

Presented By

Ms Sofie Bech Vestergaard, Aarhus University Hospital, Denmark

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 05:51

Comorbid anxiety and depression may benefit from psoriasis treatment with certolizumab

Presented By

Prof. April Armstrong, Keck School of Medicine of USC, CA, USA

Trial

Phase 3, CIMPASI-1, CIMPASI-2

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 09:47

Vortioxetine effectively reduces symptoms of depression and anxiety

Presented By

Dr Michael Christensen , H. Lundbeck A/S, Denmark

Trial

Phase 4, RECONNECT

Conference

ECNP 2021

Type

Peer-reviewed article

26 November 2021 11:45

Cannabidiol for cannabis cessation shows positive results

Presented By

Dr Tom Freeman , University of Bath, UK

Conference

ECNP 2021

Type

Peer-reviewed article

26 November 2021 11:05

Novel approaches to understanding the social brain

Presented By

Dr David Slattery, Goethe University, Germany ; Dr Joana Vieira, Karolinska Institute, Sweden

Conference

ECNP 2021

Type

Peer-reviewed article

26 November 2021 10:59

Anxiolytic activity of a novel orexin-1 receptor antagonist

Presented By

Dr Mark Schmidt, Janssen, Belgium

Conference

ECNP 2021

Type

Peer-reviewed article

26 November 2021 10:51

ECNP 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

WATERFALL, RECONNECT

Conference

ECNP 2021

20 October 2021 00:22

Possible aetiologies for COPD exacerbations – more evidence is needed

Presented By

Prof. Surya P. Bhatt, Birmingham School of Medicine, AL, USA

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Baby’s heart rate shows stress if their mother is depressed or anxious

Presented By

Mr Fabio Blanco-Dormond, University of Heidelberg, Germany

Conference

ECNP 2020

Type

Peer-reviewed article

2 November 2020 15:53

Possible causal link between eosinophilic inflammation and anxiety

Presented By

Dr Jukka Ronkainen, Course Health Research, Finland

Conference

UEGW 2020

Type

News article

2 November 2020 11:52

Microbial composition and psychological wellbeing

Presented By

Dr Luc Biedermann, University Hospital Zurich, Switzerland

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 20:03

Albuterol-budesonide reduces asthma exacerbations better than albuterol

Presented By

Prof. Reynold Panettieri Jr., Rutgers University, NJ, USA

Trial

Phase 3, BATURA

Conference

ATS 2025

26 May 2025 12:53

Anti-IL-5 therapy reduces exacerbations in coexisting asthma and COPD

Presented By

Prof. Lies Lahousse, Ghent University Hospital, Belgium

Conference

ATS 2025

26 May 2025 12:51

WAYFINDER: Tezepelumab cuts steroid use in severe asthma

Presented By

Prof. David Jackson, King's College London, UK

Trial

Phase 3, WAYFINDER

Conference

ATS 2025

26 May 2025 12:49

Barriers to clinical remission in severe asthma with biologics

Journal

Pulmonology 

2 May 2025 10:54

Novel burden score for assessing asthma severity and remission

Journal

Pulmonology 

2 May 2025 10:53

Validation of the CAD-Q questionnaire for COPD-asthma differentiation

Journal

Pulmonology 

2 May 2025 10:51

Correlation between Life’s Essential 8 Scores and asthma risk

Journal

Pulmonology 

28 April 2025 10:50

Vascular alterations in neutrophilic and mixed asthma phenotypes

Journal

Respiratory Research

28 April 2025 10:48

Comparative effectiveness of biologics in severe asthma with nasal polyps

Journal

Lung Cancer

28 April 2025 10:45

World Asthma Day: Patients call for policy change, not just awareness

28 April 2025 10:39

UCAP: Identify and treat undiagnosed COPD or asthma

Presented By

Dr Shawn Aaron, Ottawa Hospital Research Institute, Canada

Conference

ATS 2024

Type

News article

10 June 2024 17:04

Structural and functional lung improvement with dupilumab in asthma

Presented By

Dr George Washko, Brigham and Women’s Hospital, MA, USA

Trial

Phase 4, VESTIGE

Conference

ATS 2024

Type

News article

10 June 2024 16:57

sRAGE: A novel potential biomarker to assess the risk of acute respiratory events

Presented By

Dr Jinying Chen, Sichuan University, China

Conference

ERS 2023

Type

Peer-reviewed article

29 October 2023 16:12

Most severe asthma patients are candidates for biologic therapy on a global scale

Presented By

Dr Freda Yang, Imperial College London, UK

Conference

ERS 2023

Type

Peer-reviewed article

29 October 2023 16:10

Gabapentinoids increase risk of exacerbations in COPD

Presented By

Mr Alvi Rahman, McGill University, Canada

Conference

ERS 2023

Type

Peer-reviewed article

29 October 2023 15:29

Future treatment of fatigue in COPD: 4 possible targets identified

Presented By

Dr Maarten Van Herck, Ciro, the Netherlands

Trial

FAntasTIGUE

Conference

ERS 2023

Type

Peer-reviewed article

29 October 2023 15:27

Tapering from high-dose inhaled corticosteroids possible in most asthma patients treated with benralizumab

Presented By

Prof. David J. Jackson, King's College London, UK

Trial

SHAMAL

Conference

ERS 2023

Type

Peer-reviewed article

29 October 2023 15:15

Tezepelumab therapy: hints toward a disease-modifying effect?

Presented By

Prof. Christopher Brightling, University of Leicester, UK

Trial

NAVIGATOR, SOURCE, DESTINATION

Conference

ERS 2023

Type

Peer-reviewed article

29 October 2023 15:10

Digital inhaler programme improves asthma control also in the long term, but not long-term adherence

Presented By

Susanne J van de Hei, University Medal Center Groningen, the Netherlands

Trial

ACQ-5

Conference

ERS 2023

Type

Peer-reviewed article

29 October 2023 14:59

Wildfire smoke in New York: adapting to a new respiratory reality

Expert

Haillie Meek, Centers for Disease Control and Prevention, NY, USA

11 October 2023 12:36

Vitamin D for asthma protection: what is the optimal timing?

Presented By

Dr Lourdes Ramirez, Brigham and Women’s Hospital, MA, USA

Trial

Phase 3, VDAART

Conference

ATS 2023

Type

News article

12 June 2023 16:15

Practice-changing results for ensifentrine in COPD

Presented By

Prof. Antonio Anzueto, University of Texas Health San Antonio, TX, USA

Trial

Phase 3, ENHANCE-1, ENHANCE-2

Conference

ATS 2023

Type

News article

12 June 2023 16:10

Alvelestat for AATD meets primary endpoints in phase 2 trial

Presented By

Prof. Robert Stockley, University Hospital Birmingham, UK

Trial

Phase 2, ASTRAEUS

Conference

ATS 2023

Type

News article

12 June 2023 16:08

Fewer exacerbations with dupilumab in COPD with type 2 inflammation

Presented By

Prof. Klaus Rabe, LungenClinic Grosshansdorf GmbH, Germany

Trial

Phase 3, BOREAS

Conference

ATS 2023

Type

News article

12 June 2023 16:05

Remarkable results for novel biologic therapy for asthma

Presented By

Dr Benjamin Suratt, Sanofi, NJ, USA

Trial

Phase 1

Conference

ATS 2023

Type

News article

12 June 2023 16:00

Efficient detection of AECOPD with at-home vital signs monitoring

Presented By

Mr Yann Le Guillou, Biosency, France

Conference

ATS 2023

Type

News article

12 June 2023 15:55

Success for fluticasone furoate plus vilanterol in uncontrolled asthma

Presented By

Dr Philippe Bareille, GSK, UK

Conference

ATS 2023

Type

News article

12 June 2023 00:00

Looking Forward to 2023: Anticipated Medical Innovations

25 January 2023 02:35

Antibiotics cause increased risk of wheezing in severe RSV bronchiolitis 

Presented By

Prof. Avraham Beigelman, Schneider Children's Medical Center of Israel, Israel

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 21:23

Tezepelumab in asthma: mucus plugging down, lung function up

Presented By

Prof. Christopher Brightling, University of Leicester, UK

Trial

Phase 2, CASCADE

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 21:06

Digital asthma intervention improves health and reduces costs 

Presented By

Mr Luca Ponti, Amiko Digital Health, Italy

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 21:03

Digitally enhanced therapy lowers treatment burden and costs in severe asthma 

Presented By

Prof. Richard Costello, Bon Secours Hospital Dublin, Ireland

Trial

INCA-SUN

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 21:01

Mepolizumab beneficial for patients with severe eosinophilic asthma 

Presented By

Dr Rupert Jakes, GSK, UK

Trial

REALITI-A

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:59

Icenticaftor achieves results on top of triple inhalation therapy in COPD 

Presented By

Prof. Frits Franssen, Maastricht University, the Netherlands

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:50

STARR2: A new approach for treating COPD exacerbations 

Presented By

Prof. Mona Bafadhel, King’s College London, UK

Trial

Phase 4, STARR2

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:48

COPD medication not effective in symptomatic smokers with preserved spirometry 

Presented By

Prof. MeiLan Han, University of Michigan, MI, USA

Trial

Phase 3, RETHINC

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:46

Do digital tools improve physical activity in COPD?

Presented By

Prof. Andre Nyberg, University of Umeå, Sweden

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:43

Hyperpolarised gas MRI ready for clinical use

Presented By

Dr Sarah Svenningsen, McMaster University, Canada

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 20:41

ERS 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

ERS 2022

22 September 2022 02:57

Physical activity improves asthma control

Presented By

Morten Hostrup, University of Copenhagen, Denmark

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 16:30

Tailored exercise needed for COPD patients

Presented By

Prof. Andre Nyberg, Umea University, Sweden

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 16:28

Asthma increases risks around delivery

Presented By

Dr Paula Kauppi, University of Helsinki, Finland

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 16:13

PRO-ART study: unravelling the link between asthma and subfertility

Presented By

Dr Anne Hansen, Copenhagen University Hospital, Denmark

Trial

Phase 2, PRO-ART

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 16:10

Early-onset and uncontrolled asthma: strong association with recurrent pregnancy loss

Presented By

Dr Casper Tidemandsen, Copenhagen University Hospital, Denmark

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 16:08

Round-up of respiratory disease and reproduction topics

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 16:06

Severe asthma in the spotlights

Presented By

Prof. Lena Uller, Lund University, Sweden

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 15:58

Common comorbidities in severe asthma

Presented By

Dr Asger Sverrild, Bispebjerg Hospital, Denmark

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 15:56

Switching biologicals in severe asthma

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 15:53

Targeting treatable traits allows a personalised approach to management of (severe) asthma

Presented By

Dr Florence Schleich, University of Liège, Belgium

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 15:44

Exercise-induced laryngeal obstruction (EILO) is often misdiagnosed

Presented By

Dr Emil Walsted, Bispebjerg Hospital, Denmark

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 15:40

The ULANC Group: working together in CRSwNP/asthma

Presented By

Prof. Vibeke Backer, Rigshospitalet/Copenhagen University, Denmark

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 15:29

E-cigarettes impose detrimental effects on health

Presented By

Dr Linnea Hedman, Umeå University, Sweden

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 14:34

Effects of passive vaping in COPD patients

Presented By

Prof. Torben Sigsgaard, Aarhus University, Denmark

Conference

NLC 2022

Type

Peer-reviewed article

17 August 2022 14:32

NLC 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

NLC 2022

17 August 2022 09:20

MANDALA and DENALI pattern success for albuterol-budesonide in asthma

Presented By

Prof. Alberto Papi, University of Ferrara, Italy & Dr Bradley Chipps, Capital Allergy & Respiratory Disease Center, CA, USA

Trial

Phase 3, MANDALA, DENALI

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:05

ACOUSTICS data sounds good for adolescent asthma exacerbations

Presented By

Prof. Stanley Szefler, Children’s Hospital Colorado, CO, USA

Trial

Phase 3, ACOUSTICS

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:02

Type 2 asthma in children managed by dupilumab, despite atopic comorbidities

Presented By

Prof. Theresa Guilbert, University of Cincinnati, OH, USA

Trial

Phase 3, Liberty Asthma VOYAGE

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:00

NAVIGATOR steers asthma patients to tezepelumab

Presented By

Prof. Njira Lugogo, University of Michigan, MI, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:57

High-intensity interval training slashes daily corticosteroids in asthma

Presented By

Dr Anders Pitzner-Fabricius, Rigshospitalet Copenhagen, Denmark

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:55

Three’s a crowd for triple therapy in COPD

Presented By

Prof. Claus Vogelmeier, Philipps-University Marburg, Germany

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:40

Higher 1-year COPD mortality after hospitalisation for White patients

Presented By

Dr Snigdha Jain, Yale School of Medicine, CT, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:39

Reducing dyspnoea in chronic lung disease through weight loss

Presented By

Dr Maria Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:37

CT-evident mucus plugs in COPD associated with death

Presented By

Dr Alejandro Diaz, Brigham and Women’s Hospital, MA, USA

Trial

COPDGene

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:35

Home-based rehabilitation improves COPD: a randomised study

Presented By

Dr Roberto Benzo, Mayo Clinic Rochester, MN, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 12:33

No screening evidence for COPD

Presented By

Prof. Carol Mangione, University of California at Los Angeles, CA, USA

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 11:44

Telemedicine has mixed influence on costs of asthma care

Journal

The Journal of Allergy and Clinical Immunology: In Practice

17 June 2022 16:07

ATS 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ATS 2022

9 June 2022 07:34

Obesity may hinder response to immunotherapy for allergies, asthma, mouse study suggests

Journal

Nature

6 April 2022 23:57

Live attenuated nasal-spray flu vaccine safe in kids with asthma

Journal

Pediatrics

30 March 2022 15:58

Simple screening tools could help identify COPD in low-, middle-income countries

Journal

JAMA

20 January 2022 20:25

Secondhand vaping linked with respiratory symptoms in young adults

Journal

Thorax

17 January 2022 21:45

Dupilumab cuts severe asthma exacerbations by 59% in children aged 6 to 11

Journal

The New England Journal of Medicine

12 December 2021 23:00

Immune-mediated diseases tied to risk of cancer

Journal

JAMA Oncology

9 December 2021 21:17

Understudied low-lung-function state tied to increased risk of respiratory problems and death

Journal

The Lancet Respiratory Medicine

11 November 2021 16:44

Fear of COVID-19 related to dyspnoea in COPD patients

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:29

Rhinovirus bronchiolitis increased risk of recurrent wheezing and asthma

Presented By

Dr Heidi Makrinioti, Imperial College London, UK

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:28

Livestock farming affected the airway microbiome of COPD patients

Presented By

Mr Warner van Kersen, Utrecht University, the Netherlands

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:27

Adherence to singing training similar to standard physical therapy in COPD patients

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:27

COPD symptoms and lung function related to sleep quality

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:26

Reduction of COPD severe acute exacerbations by candidate vaccine

Presented By

Prof. Stefan Andreas, Gastarzt Abteilung Pneumologie der Medizinischen Klinik II Gießen, Germany

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:26

The effect of the pandemic on the discharge diagnosis of older COPD patients

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:25

Lower influenza vaccination coverage in children with chronic conditions

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:24

Biomarkers do not discriminate severe from severe uncontrolled asthma

Presented By

Dr Bo Ding, AstraZeneca, Sweden

Trial

NOVELTY

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:21

Increased blood neutrophiles in patients with obesity and asthma

Presented By

Dr Helena Backman, Umea University, Sweden

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:20

Dynamics of environmental pollution during and after COVID-19 lockdown

Trial

POLCOV

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:20

Magnesium supplements improved lung function in asthma patients

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:19

Blood inflammatory phenotypes associated with clinical symptoms of asthma

Presented By

Dr Tajidine Tsiavia, University of Paris-Saclay, France

Conference

ERS 2021

Type

Peer-reviewed article

9 November 2021 10:19

Paradoxical bronchospasm may go unrecognized in patients with COPD or asthma

Conference

CHEST 2021 Annual Meeting

21 October 2021 16:23

ERS 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ERS 2021

23 September 2021 12:51

Circadian system implicated in asthma worsening at night

Journal

Proceedings of the National Academy of Sciences of the United States of America

17 September 2021 22:55

Hotter weather may fuel spike in COPD flare-ups

Conference

ERS International Congress 2021

7 September 2021 16:24

Restoring pulmonary endothelial cells reverses emphysema in mice

Journal

Journal of Experimental Medicine

29 July 2021 16:33

Vaping identified as risk factor for asthma

Presented By

Prof. Theresa To, The Hospital for Sick Children, ON, Canada

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:56

Obesity: A risk factor for new-onset asthma and worse asthma control

Presented By

Prof. Fernando Holguin, University of Colorado Asthma Research and Education, CO, USA

Trial

Cohort study, CARDIA

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:52

Metabolic dysfunction and lung disease: children are no small adults

Presented By

Prof. Erick Forno, University of Pittsburgh, PA, USA

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:52

Possible aetiologies for COPD exacerbations – more evidence is needed

Presented By

Prof. Surya P. Bhatt, Birmingham School of Medicine, AL, USA

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Does COPD plus COVID-19 equal higher mortality?

Presented By

Dr Jacob Schwartz, Lenox Hill Hospital, NY, USA

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Biomarkers for acute exacerbations in COPD are required

Presented By

Prof. Don D. Sin, University of British Columbia, BC, Canada

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Severe exacerbations: A key driver of all-cause mortality in COPD patients

Presented By

Prof. Manoj J. Mammen, Jacobs School of Medicine and Biomedical Sciences, NY, USA

Trial

Phase 3, IMPACT

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Men and women with COPD differ in many ways

Presented By

Dr Franziska Trudzinski, University Hospital Centre Heidelberg, Germany

Trial

Cohort study, cosyconet

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

Younger adults with COPD at higher health risk than previously thought

Presented By

Dr Alina J. Blazer, University of Toronto, ON, Canada

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:50

“As-needed” inhaled corticosteroid therapy for mild asthma – what is the evidence?

Presented By

Prof. Kaharu Sumino, Prof. Anne Dixon

Trial

SYGMA 1 and 2, PRACTICAL, START

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:48

IL-4/13 blocker successful in treatment of paediatric moderate-to-severe asthma

Presented By

Prof. Leonhard B. Bacharier, Vanderbilt University Medical Center, TN, USA

Trial

VOYAGE

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:48

Benralizumab lives up to its phase 3 results in real-world findings

Presented By

Dr Donna Carstens, AstraZeneca, Wilmington, DE, USA

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:48

Tezepelumab – good success rates in various types of severe asthma

Presented By

Prof. Michael E. Wechsler, National Jewish Health, Denver, CO, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2021

Type

Peer-reviewed article

5 July 2021 13:48

Frequent snoring tied to increased asthma symptoms, health care use in kids

Journal

Journal of Allergy and Clinical Immunology: In Practice

16 June 2021 19:48

HRT tied to increased risk of severe asthma exacerbation

Journal

Journal of Allergy and Clinical Immunology: In Practice

26 March 2021 19:03

Dupilumab an option when other targeted agents fail in aspirin-exacerbated respiratory disease

Journal

Journal of Allergy and Clinical Immunology: In Practice

5 March 2021 17:37

No drop in oxygen saturation when asthma patients wear masks

Conference

AAAAI Virtual Annual Meeting

3 March 2021 17:07

Grandmother’s smoking tied to asthma risk, lung function in some men

Journal

Thorax

1 March 2021 17:53

AstraZeneca-Amgen drug could widen treatment options for severe asthma

26 February 2021 15:00

Bronchial thermoplasty benefits for uncontrolled asthma sustained at 10 years

Journal

Lancet Respiratory Medicine

19 February 2021 17:56

Proton pump inhibitor use tied to childhood asthma

Journal

JAMA Pediatrics

8 February 2021 23:02

Benralizumab improves health-related quality of life in severe eosinophilic asthma

Journal

Lancet Respiratory Medicine

15 January 2021 16:14

Screen COPD patients with worsening lung function for pulmonary embolism?

Journal

JAMA

5 January 2021 19:28

Disinfecting during pandemic puts asthmatics at risk

Journal

Journal of Allergy and Clinical Immunology

4 January 2021 23:36

Asthma inhaler sensors improve pediatric asthma control

Journal

Pediatrics

24 December 2020 22:28

Halting asthma medication for pregnancy tied to adverse perinatal outcomes

9 December 2020 23:01

New asthma guidelines advise single maintenance and reliever therapy

Journal

JAMA

7 December 2020 14:35

Children with exercise-induced respiratory symptoms may get conflicting diagnoses

Journal

Pediatric Pulmonology

24 November 2020 21:19

Vitamin D supplement improves asthma control in adults with deficiency

Journal

Thorax

23 November 2020 17:45

Anti-IL-5 biologics effective for up to two years in severe asthma, but residual disease remains

Journal

Journal of Allergy and Clinical Immunology in Practice

29 October 2020 22:45

Smartphone-based cough detection helpful in predicting asthma deterioration

Presented By

Dr Frank Rassouli, Cantonal Hospital St. Gallen, Switzerland

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 19:53

The role of chronic symptoms as early biomarkers of COPD development

Presented By

Dr James Allinson, Imperial College London, UK

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:29

Urgent call for studies in COPD patients aged 40-60 years

Presented By

Prof. Wisia Wedzicha , Imperial College London, UK

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:25

Nasal high-flow therapy: a novel treatment option for hypercapnic COPD patients

Presented By

Dr Jens Bräunlich, Kliniken Aurich-Emden-Norden, Germany

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:10

Exacerbation history is a reliable predictor of future exacerbations

Presented By

Prof. Claus Vogelmeier, Philipps University of Marburg, Germany

Trial

Cohort study, AvoidEx

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:07

Singing training effective as physical rehabilitation in COPD

Presented By

Prof. Uffe Bødtger, Nætved Hospital, Denmark

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 18:02

Mild asthma: A fundamental change in management

Presented By

Prof. Roland Buhl, Johannes Gutenberg University of Mainz, Germany

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 17:55

Dupilumab shows long-term efficacy in asthma patients

Presented By

Dr Michael Wechsler, Prof. Chris Brightling

Trial

LIBERTY ASTHMA TRAVERSE, LUSTER

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 17:47

Severe asthma: Oral corticosteroids maintenance therapy associated with toxicity

Presented By

Prof. Njira Lugogo, University of Michigan, USA

Trial

CHRONICLE

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 17:42

First-in-class tyrosine kinase inhibitor shows promise in severe asthma

Presented By

Prof. Pascal Chanez, Aix-Marseille Université, France

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 17:39

Predicting individual effectiveness of biologics in severe asthma

Presented By

Prof. Celeste Porsbjerg, Bispebjerg-Frederiksberg University Hospital, Denmark

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 17:34

Current prediction tools underestimate exacerbation risk of severe COPD patients

Presented By

Mr Spencer Keene, Maastricht University, the Netherlands

Trial

ECLIPSE

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 16:57

IL-5 antagonist showed efficacy in chronic rhinosinusitis with nasal polyps

Presented By

Dr Claire Hopkins, Guy’s and St Thomas Hospital and King’s College London, UK

Trial

Phase 3, SYNAPSE

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 16:42

Treatment according to genotype: The future of asthma therapy?

Presented By

Dr Tom Ruffles, Brighton & Sussex Medical School, UK

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 15:49

Oral cannabinoid drugs may worsen COPD outcomes

Journal

Thorax

27 October 2020 16:21

Asthma rescue with budesonide-formoterol cuts short-term flare risk

Journal

Lancet Respiratory Medicine

9 October 2020 17:19

For COPD with nocturnal hypoxemia, nighttime oxygen has no survival benefit

Journal

New England Journal of Medicine

16 September 2020 23:00

Bronchitis in childhood tied to worse lung health in adulthood

Conference

ERS 2020

11 September 2020 23:03

AstraZeneca’s asthma drug succeeds late-stage nasal polyposis study

10 September 2020 15:56

Limited evidence supports escalation of therapy for acute asthma exacerbations in kids

Journal

Cochrane Database of Systematic Reviews

4 September 2020 19:50

Smart shirt as a device to measure tidal volumes in real-life setting

Presented By

Ms Denise Mannée, Radboud University Medical Centre, the Netherlands

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 22:19

COPD patients harbouring Pseudomonas Aeruginosa face high risk of hospitalisation

Presented By

Dr Josefin Eklöf, Copenhagen University Hospital, Denmark

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 22:01

Exercise with virtual reality beneficial for COPD patients

Presented By

Dr Sebastian Rutkowski, Opole University of Technology, Poland

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 21:21

One blood eosinophil count is sufficient to guide ICS therapy

Presented By

Prof. Mona Bafadhel, , University of Oxford, United Kingdom

Trial

IMPACT

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 21:03

Female COPD patients frequently suffer from anxiety and depression

Presented By

Mr El-Hassane Ouaalaya, Bordeaux University, France

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 20:05

COPD patients do not benefit from azithromycin therapy longer than a year

Presented By

Dr Sander Talman, Amphia Hospital, the Netherlands

Trial

Cohort study, COLUMBUS

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 16:28

Pneumococcal vaccines: an effective way to reduce COPD hospitalisations

Presented By

Prof. Antoni Torres, University Hospital Clinic Barcelona, Catalonia, Spain

Trial

CAPiTA

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 16:06

Dual bronchodilation improves ventilation dynamics in COPD patients

Presented By

Prof. Jens Hohlfeld, Hannover Medical School, Germany

Trial

Cohort study, CLAIM

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 15:07

Holistic view on asthma

Expert

Prof. Zuzana Diamant, Skåne University Hospital Lund, Sweden; Charles University and Thomayer Hospital, Czech Republic; and University Medical Center Groningen, the Netherlands

Conference

ERS 2019

Type

Peer-reviewed article

28 November 2019 14:55

Dupilumab improves outcomes in patients with severe chronic rhinosinusitis with nasal polyps and comorbid asthma

Presented By

Dr Jorge Maspero, Fundación CIDEA, Argentina

Trial

Phase 3, SINUS-24, SINUS-52

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 23:02

Benralizumab does not ameliorate COPD exacerbations (GALATHEA/TERRANOVA trials)

Presented By

Prof. Gerard Criner, Temple University, USA

Trial

Phase 3, GALATHEA, TERRANOVA

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 21:35

Ensifentrine for COPD maintenance treatment

Presented By

Dr Dave Singh, University of Manchester, UK

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 20:17

Treatable traits in chronic inflammatory airway disease: back to basics

Presented By

Prof. Zuzana Diamant, Skåne University Hospital Lund, Sweden; Charles University and Thomayer Hospital, Czech Republic; and University Medical Center Groningen, the Netherlands

Trial

GALATHEA, TERRANOVA,LIBERTY ASTHMA QUEST

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 12:46

Aclidinium bromide delays COPD exacerbation without increased MACE risk

Presented By

Prof. Kenneth Chapman, University of Toronto, Canada

Trial

ASCENT-COPD

Conference

ATS 2019

Type

Peer-reviewed article

23 July 2019 11:20

[Long Read] Current Look on Asthma

Presented By

Prof. Zuzana Diamant, Skåne University Hospital Lund, Sweden; University Medical Center Groningen, the Netherlands

Trial

COSMEX, COSMOS, BORA

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 23:25

Landmark triple therapy trials

Presented By

Prof. Leonardo Fabbri, University of Modena and Reggio Emilia, Italy; Dr Konstantinos Kostikas, Novartis Pharma, Switzerland

Trial

Phase 3, IMPACT

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 23:05

Endoscopic treatment of asthma

Presented By

Prof. Pallav Shah, Imperial College London, United Kingdom; Dr Karin Klooster, University Medical Center Groningen, the Netherlands

Type

Peer-reviewed article

7 November 2018 22:49

ICS: to use or not to use?

Presented By

Dr Gary Ferguson, Pulmonary Research Institute of Southeast Michigan, USA

Trial

KRONOS

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 22:13

MABA, and novel LAMA

Presented By

Dr Ioannis Psallidas, University of Oxford, United Kingdom; Dr James Donohue, University of North Carolina at Chapel Hill, USA

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 21:17

Macrolide antibiotics and trial with azithromycin

Presented By

Prof. Wim Janssens, University Hospital Leuven, Belgium

Trial

BACE

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 20:21